1. Plant-Derived Alkaloids: The Promising Disease-Modifying Agents for Inflammatory Bowel Disease
   Jiao Peng et al, 2019, Frontiers in Pharmacology CrossRef
2. Mas‐related G protein‐coupled receptors in gastrointestinal dysfunction and inflammatory bowel disease: A review
   Patrick Hawker et al, 2024, British Journal of Pharmacology CrossRef
3. Effects of Myricitrin and Relevant Molecular Mechanisms
   Rui Ma et al, 2020, Current Stem Cell Research & Therapy CrossRef
4. Oral Nano-Delivery Systems for Colon-Targeted Drug Delivery of Traditional Chinese Medicine in Ulcerative Colitis
   Mohammad Javed Ansari et al, 2023, Bionatura CrossRef
5. Natural Products: Experimental Efficient Agents for Inflammatory Bowel Disease Therapy
   Fan Cao et al, 2020, Current Pharmaceutical Design CrossRef
6. CD26 Deficiency Controls Macrophage Polarization Markers and Signal Transducers during Colitis Development and Resolution
   Iva Vukelic et al, 2022, International Journal of Molecular Sciences CrossRef
7. Sinomenine hydrochloride ameliorates dextran sulfate sodium‑induced colitis in mice by modulating the gut microbiota composition whilst suppressing the activation of the NLRP3 inflammasome
   Yan Zhou et al, 2021, Experimental and Therapeutic Medicine CrossRef
8. From mundane to classic: Sinomenine as a multi‐therapeutic agent
   Dan Li et al, 2023, British Journal of Pharmacology CrossRef
9. Evaluation of the Mechanism of Sinomenii Caulis in Treating Ulcerative Colitis based on Network Pharmacology and Molecular Docking
   Juan Tian et al, 2024, Current Computer-Aided Drug Design CrossRef